Private Placements, Capital Formation,
Restructuring & Recapitalizations



SCOLR, Inc. Common Stocks and Warrants - February 2004

SCOLR, Inc. is a biopharmaceutical company leveraging proprietary, patented technologies in drug delivery to introduce novel prescription drugs, OTC products and dietary supplements. The Company is moving forward with human clinicals for extended release formulations of Ibuprofen, Pseudoephedrine and Raloxifene based on its proprietary CDT® drug delivery platform. They are based out of Bothell, Washington.

The information contained herein does not constitute a solicitation of any order to buy or sell any securities. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Taglich Brothers, Inc.